Germline testing for predisposition to ovarian/breast cancer should be routinely recommended in all patients with invasive epithelial ovarian cancer

被引：0

作者：

Wheeler L.J. ^{[1
]}

Guntupalli S. ^{[1
]}

机构：

[1] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Colorado Denver, School of Medicine, Anschutz Medical Campus, 12631 East 17th Avenue B198-6, Aurora, 80045, CO

来源：

Indian Journal of Gynecologic Oncology | 2017年 / 15卷 / Suppl 1期

关键词：

Genetic testing; Ovarian cancer; Universal screening;

D O I：

10.1007/s40944-017-0164-7

中图分类号：

学科分类号：

摘要：

Given the marked prevalence of germline mutations among women with ovarian cancer, we recommend universal BRCA genetic screening, regardless of patient age or family history. © Association of Gynecologic Oncologists of India 2017.

引用

页码：S27 / S30

页数：3